Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer
Open Access
- 1 January 2001
- Vol. 3 (5) , 451-456
- https://doi.org/10.1038/sj.neo.7900193
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Conditionally replicating herpes vectors for cancer therapyJournal of Clinical Investigation, 2000
- Systemic Antitumor Immunity in Experimental Brain Tumor Therapy Using a Multimutated, Replication-Competent Herpes Simplex VirusHuman Gene Therapy, 1999
- Local and Systemic Therapy of Human Prostate Adenocarcinoma with the Conditionally Replicating Herpes Simplex Virus Vector G207Human Gene Therapy, 1999
- Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor ImmunityHuman Gene Therapy, 1999
- Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsGene Therapy, 1998
- Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomasNature Medicine, 1995
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995
- Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Enhanced Replication of Herpes Simplex Virus Type 1 in Human CellsJournal of Dental Research, 1991